instance, in ECASS III the rate of SICH was 2.4% in the rt-PA group using the ECASS III protocol definition, but 7.9% using the NINDS definition.
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Studies evaluating predictors of post-thrombolytic ICH have used various definitions, which may account for some of the variability in identified predictors of post-thrombolysis ICH between studies.
Risk Factors for Post-thrombolysis Intracerebral Hemorrhage
Lansberg et al. recently performed a systematic review of the literature and reported several risk factors consistently associated in multiple studies with post-thrombolysis SICH. 12 In 12 studies that met their inclusion criteria, early computed tomography (CT) hypodensity, elevated serum glucose or history of diabetes, and symptom severity as defined by the NIHSS were the factors most consistently associated with an increased risk of post-thrombolysis SICH. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Numerous other risk factors have been reported in individual studies, including advanced age, longer time to treatment, high systolic blood pressure, low platelet count, history of congestive heart failure, low plasminogen activator inhibitor levels, prior antiplatelet use, non-smoking status, low-density lipoprotein levels, imaging characteristics on magnetic resonance imaging (MRI), and deviations from treatment protocols. 12, [19] [20] [21] [23] [24] [25] [26] [27] [28] [29] However, the association between these factors and risk for ICH Even when independent, it is difficult to quantify the incremental additive risk associated with the presence of multiple risk factors in the individual patient. The development of clinical risk scores attempts to fill this need.
Two recent publications have incorporated some of the above variables into scoring systems to better predict SICH and allow risk stratification of patients receiving thrombolytic therapy for acute ischemic stroke.
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The Hemorrhage After Thrombolysis Score and obvious early CT hypodensity as the most important factors for determining bleeding risk after thrombolysis. These risk factors were then categorized and assigned a value of 0, 1, or 2 based on their determined import, with a maximum cumulative score of 5 (see Table 1 ).
The HAT score was evaluated in rt-PA-treated patients in the NINDS trial (n=302) and in a small prospective cohort (n=98) of patients treated clinically at the authors' institution. SICH was defined differently in the two groups: the NINDS definition was used in the retrospective cohort, but the ECASS III definition was used in the prospectively collected group of patients.
The rate of total ICH and SICH increased with increasing HAT scores in the NINDS trial group and in the prospective cohort. In the combined analysis of both groups, the total risk for ICH was 6, 16, 23, 36, and 78%
for HAT scores of 0, 1, 2, 3, and >3, respectively, and the risk for SICH was 2, 5, 10, 15, and 44% for HAT scores of 0, 1, 2, 3, and >3, respectively (see Table 2 ). There were no other combinations of reported risk factors that improved the reliability of the model using c-statistics. It should be noted that the derivation and refinement of the HAT score appears to have utilized the larger NINDS data set in which the score was also tested, such that the score has only truly been independently validated in the single small cohort of patients at the authors' own institution.
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The Multicenter Stroke Survey Scale
The Multicenter rt-PA Stroke Survey group has also developed and published a clinical risk score for predicting ICH after rt-PA. 
